EntreMed (ENMD)

Add to Watchlists Create an Alert
1.77 -0.03  -1.67%   NASDAQ May 23, 4:44PM BATS Real time Currency in USD

EntreMed SG&A Expense Quarterly:

0.5351M for Dec. 31, 2012
View Full Chart

EntreMed SG&A Expense Quarterly Chart

    EntreMed Historical SG&A Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 0.5351M
    Sept. 30, 2012 0.5646M
    June 30, 2012 0.6015M
    March 31, 2012 1.097M
    Dec. 31, 2011 0.5219M
    Sept. 30, 2011 0.5566M
    June 30, 2011 0.7199M
    March 31, 2011 1.253M
    Dec. 31, 2010 0.8843M
    Sept. 30, 2010 0.6916M
    June 30, 2010 0.7707M
    March 31, 2010 1.051M
    Dec. 31, 2009 1.022M
    Sept. 30, 2009 0.9118M
    June 30, 2009 1.011M
    March 31, 2009 1.160M
    Dec. 31, 2008 2.490M
    Sept. 30, 2008 1.552M
    June 30, 2008 1.740M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About SG&A Expense

    SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

    The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
    Learn More

    Get data for

    ENMD SG&A Expense Quarterly Benchmarks

    Companies
    Vical 2.659M
    Strategic Diagnostics 2.768M
    ARCA biopharma 0.648M

    ENMD SG&A Expense Quarterly Rankings

    Overall 40th percentile
    4779 of 8006
    Sector 15th percentile
    583 of 686 in Healthcare
    Industry 16th percentile
    206 of 248 in Biotechnology

    ENMD SG&A Expense Quarterly Range, Past 5 Years

    Minimum 0.5219M Dec 2011
    Maximum 2.490M Dec 2008
    Average 1.007M